APA (7th ed.) Citation

JJ, Z., KY, F., YH, C., J, T., S, D., SC, L., . . . JSJ, L. (2023). Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer. Cancers, 15(18), . https://doi.org/10.3390/cancers15184558

Chicago Style (17th ed.) Citation

JJ, Zhao, Fong KY, Chan YH, Tey J, Dawood S, Lee SC, Finn RS, Sundar R, and Lim JSJ. "Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer." Cancers 15, no. 18 (2023). https://doi.org/10.3390/cancers15184558.

MLA (9th ed.) Citation

JJ, Zhao, et al. "Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer." Cancers, vol. 15, no. 18, 2023, https://doi.org/10.3390/cancers15184558.